Neurotech opens first site for phase III autism trial
First clinical site activated and open for recruitment for Neurotech’s Phase III Beyond Harmony trial Study to evaluate NTI164 in children with autism spectrum disorder targeting core symptoms and neuroinflammation Additional clinical sites expected to …